Cannabis and hemp company Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) revealed on Tuesday the completion of the acquisition of the licensed cannabis company Cáñamo y Fibras Naturales, SL, based in the Province of Alicante in Spain.
This all cash acquisition allows Canopy Growth to expand its European production footprint into one of the most ideal growing regions in the world as well as complement its existing 430,000 square foot licensed production site in Odense, Denmark and its world-class ISO 13485 internationally certified Storz and Bickel facility in Germany.
With a focused team, Cafina has already established a small greenhouse for research-related medical cannabis production, focused on crop-related R&D and the sale of hemp seed, received its general and research licence from the Spanish Agency for Medicines and Health Products (AEMPS) and a hemp licence for the cultivation of cannabis sativa (
Charles River Laboratories launches AMAP to reduce animal testing reliance
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
GSK's meningitis vaccine candidate accepted for FDA review
Innovent Biologics names new Oncology CMO
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients
AbbVie announces interim evaluation of Atogepant Phase three, open-label 156-week extension study